Dyslipidemias in type 2 diabetes mellitus patients in Nnewi South-East Nigeria

Annals of African Medicine

Volumn 10, Issue 4, 2011, Pages 285-289

  Jisieike Onuigbo, N N ^a   Unuigbe, E I ^b   Oguejiofor, C O ^a  

^a NNAMDI AZIKIWE UNIVERSITY   (Nigeria)

^b UNIVERSITY OF BENIN   (Nigeria)

Author keywords

Dyslipidemias; Nigeria; type 2 diabetes mellitus

Indexed keywords

CHOLESTEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN; LIPID; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; BODY HEIGHT; BODY WEIGHT; CROSS-SECTIONAL STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; DISEASE DURATION; DYSLIPIDEMIA; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTRIGLYCERIDEMIA; MAJOR CLINICAL STUDY; MALE; NIGERIA; NON INSULIN DEPENDENT DIABETES MELLITUS; PREVALENCE; SEX RATIO; SYSTOLIC BLOOD PRESSURE;

CHI-SQUARE DISTRIBUTION; CHOLESTEROL, HDL; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; DISEASE PROGRESSION; DYSLIPIDEMIAS; FEMALE; HOSPITALS, TEACHING; HUMANS; HYPERTRIGLYCERIDEMIA; MALE; MIDDLE AGED; NIGERIA; PREVALENCE; RISK ASSESSMENT;

EID: 81755178292     PISSN: 15963519     EISSN: 09755764     Source Type: Journal    
DOI: 10.4103/1596-3519.87045     Document Type: Article

References (25)

1. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Cir 2002;106:3143-421.
2. Ginsberg HN. Identification and treatment of hypertriglyceridemia as a risk factor for coronary heart disease. Curr Cardiol Rep 1999;1:2337.
3. Ballantyne CM, Grundy SM, Oberman A et al. Hyperlipidemia: Diagnostic and therapeutic perspectives. J Clin Endocrinol Metab 2000;85:208997.
4. Grundy P. Cardiovascular diseases remain nation's leading cause of death. J Am Med Assoc 1992;267:3358.
5. Coronary heart disease mortality trends among whites and blacks Appalachia and United States, 19801993. MMWR Morb Mortal Wkly Rep 1998;47:100512.
6. Njeleka MA, NegishiH, Nara Y, Sato T, Tomohiro M, Kuga S et al. Obesity and Lipid profiles in middle aged men and women in Tanzania. East Afr Med J 2002;79:5864.
7. Garg A, Grundy SM. Management of dyslipidemia in NIDDM. Diabetes Care 1990;13:153.
8. O'Brien T, Nguyen TT, Zimmerman BR. Hyperlipidemia and diabetes mellitus. Mayo Clin Proc 1998;73:969.
9. Haffner SM, Stern MP, Hazuda HP, Mitchell BD, Patterson JK. Cardiovascular risk factors in confirmed prediabetic individuals. Does the clock for coronary heart disease start ticking before the onset of clinical diabetes? J Am Med Assoc 1990;263:2893.
10. World Health Organization (WHO)/International Society of Hypertension. Guidelines for the management of hypertension. J of Hypertension 1999;17:1513.
11. Preventing and Managing the Global EpidemicReport of a WHO Consultation on Obesity, 35 June 1997, Geneva. Interim version report No.: WHO/NUT/NCD/98.1.
12. World Health Organization (WHO). Consultat. Report of WHO Scientific Group; Cardiovascular disease risk factors; new areas for research. WHO Technical report series. No 841. WHO Geneva 1994.
13. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972;18:499-502.
14. Vezi ZB, Naidoo DP. Dyslipidemia among Black Patients with Type 2 Diabetes. Cardiovasc J S Afr 2005;16:1948.
15. AgbolaAbu CF, Onabolu A. Plasma Lipid Level in patients attendingIgbinedion Hospital and Medical Research Centre, Okada, Edo State. Nigeria. Nig Med J 2000;38:15.
16. Puepet FH, Agaba EI, Chuhwak EK. Some metabolic abnormalities in type 2 diabetic patients in Jos, north central Nigeria. Niger J Med 2003;12:1937.
17. Okafor CI, Fasanmade OA, Oke DA. Pattern of dyslipidaemia among Nigerians with type 2 diabetes mellitus. Niger J Clin Pract 2008;11:2531.
18. AlAdsani A, Memon A, Suresh A. Pattern and Determinants of Dyslipedemia in Type 2 Diabetes Mellitus patients in Kuwait. Acta Diabetol 2004;41:1295.
19. Odenigbo CU, Oguejiofor OC, Odenigbo UM, Ibeh CC, Ajaero CN, Odike MA. Prevalence of dyslipidaemia in apparently healthy professionals in Asaba, South South Nigeria. Niger J Clin Pract 2008;11:3305.
20. National Center for Health Statistics. Plan and operation of the second national health interview survey1976-1980. In Vital and Health Statistics. Washington, DC: US Government Printing Office; Ser 1, No.:15 DHHS Publication 1981 p 811317.
21. Goldberg RB, Mellies MJ, Sacks FM, Moyé LA, Howard BV, Howard WJ, et al. Cardiovascular events and their reduction with pravastatin in diabetic and glucoseintolerant myocardial infarction survivors with average cholesterol levels: Subgroup analyses in the cholesterol and recurrent events (CARE) trial. The Care Investigators. Circulation 1998;98:25139.
22. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. The Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group. N Engl J Med 1998;339:13497.
23. Naheed T, Khan A, Masood G, Yunus BB, Chaudry MA. Dyslipedemias in type II diabetes Mellitus patients in a teaching hospital of Lahore, Pakistan. Pak J Sci Oct Dec 2003;19:2836.
24. Agbola Abu CF, Ohwovoriole AE, Akinlade KS. The effect of glycaemic control on the prevalence and pattern of dyslipedemia in Nigerian patients withnewly diagnosed noninsulin dependent diabetes. West Afr J Med 2000;19:275.
25. Akpa MR, Agomuoh DI, Alasia DD. Lipid Profile of Healthy Adult Nigerians in Port Harcourt, Nigeria. Niger J Med 2006;15:1373.